NCT00337558View on ClinicalTrials.gov

A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)

PHASE4CompletedINTERVENTIONAL
Enrollment

643

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Overactive BladderUrinary IncontinenceUrge Incontinence
Interventions
DRUG

Solifenacin succinate

tablet

BEHAVIORAL

Simplified bladder training

Instructions

Trial Locations (64)

331

Zwijndrecht

1090

Brussels

1200

Brussels

2020

Antwerp

2031

Randwick

2217

Kogarah

2334

Leiden

3168

Clayton

3800

Sint-Truiden

4066

Auchenflower

5022

Tilburg

6043

Roermond

8500

Kortrijk

9000

Ghent

20092

Milan

31400

Toulouse

101000

Moscow

117815

Moscow

119049

Moscow

119415

Moscow

125206

Moscow

197098

Saint Petersburg

Unknown

Concord

Parkville

Ghent

La Louvière

Annecy

Arras

Bordeaux

Landerneau

Marseille

Paris

Rouen

Saint-Louis

Thionville

Valenciennes

Vernon

Budapest

Kecskemét

Tatabánya

Bari

Cinisello Balsamo

Como

Genova

Naples

Avilés

Burgos

Madrid

Manacor

Marbella

Santander

Santiago de Compostela

Seville

Ankara

Istanbul

586 01

Jihlava

460 63

Liberec

772 00

Olomouc

326 00

Pilsen

147 00

Prague

H-1145

Budapest

H-4400

Nyíregyháza

00-846

Warsaw

02-520

Warsaw

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Europe B.V.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00337558 - A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) | Biotech Hunter | Biotech Hunter